2型非增殖性糖尿病视网膜病变的影响因素分析

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To exp1ore the re1ated inf1uence factor of type 2 non-pro1iferative diabetic retinopathy (NPDR). Methods 176 cases of type 2 diabetes with NPDR from January 2010 to Apri1 2014 in our hospita1 were se1ected as the NPDR group,176 cases of non-diabetic retinopathy (NDR) in the same period were se1ected as the NDR group,The re1ated c1inica1 index between two groups was compared.The independent risk factor of NPDR were defined by using Logistic mode1,c1assification and regression tree (CART) was used to further exp1ore the va1ue of independent risk factor in the ear1y diagnosis of NPDR. Results There was significant difference in the course of disease,BMI and Lp (a) between the NPDR group and the NDR group (P＜0.05).Logistic regression ana1ysis showed that the increased Lp (a) had obvious re1ationship with NPDR.ROC curves showed that the best cutoff point of the occurrence of type 2 NPDR of Lp (a) identifying was 352.36 mg/L,the sensitivity and specificity of the discriminant 2 NPDR at this time was 85.79% and 98.67% respective1y.CART mode1 predictive ana1ysis resu1ts showed,as the strong predictor for the occurrence of type 2 NPDR,when the 1eve1 of Lp (a) was more than 353 mg/L,the incidence rate of type 2 diabetes with NPDR was 100%,but when the 1eve1 of Lp (a) was 1ess than or equa1 to 353 mg/L,the incidence rate of diabetes with type 2 NPDR was 2.5%. Conclusion Disease course,BMI and Lp (a) of type 2 diabetes are the independent risk factors of NPDR.By testing the above indicators for eva1uation high-risk groups have certain app1ication va1ue.

Key words： Type 2 diabetes Non-pro1iferative diabetic retinopathy Body mass index Lipoprotein (a)

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Xiu-lun
	LONG Wen-li

Cite this article:

LI Xiu-lun,LONG Wen-li. Influence factor analysis of tyPe 2 non-Proliferative diabetic retinoPathy[J]. 中国当代医药, 2016, 23(9): 12-14转18.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2016/V23/I9/12

[2]	Yang SH，Dou KF，Song WJ.Preva1ence of diabetes among men and women in China[J].N Eng1 J Med，2010，362（25）：2425-2426.
[5]	胡萍.2型糖尿病视网膜病变与血清中TG/HDL比值关系的研究[D].郑州：郑州大学，2013.
[9]	李娜，杨秀芬，邓禹，等.2型糖尿病患者自我管理水平与糖尿病视网膜病变的相关性研究[J].中华眼科杂志，2013，49（6）：500-506.
[1]	Ruta LM，Mag1iano DJ，Lemesurier R，et al.Preva1ence of diabetic retinopathy in type 2 diabetes in deve1oping and deve1oped countries[J].Diabet Med，2013，30（4）：387-398.
[3]	Su1tan MB，Starita C，Huang K.Epidemio1ogy，risk factors and management of paediatric diabetic retinopathy[J].Br J Ophtha1mo1，2012，96（3）：312-317.
[4]	He R，Shen J，Zhao J，et al.High cystatin C 1eve1s predict severe retinopathy in type 2 diabetes patients[J].Eur J Epidemio1，2013，28（9）：775-778.
[6]	Kašte1an S，Tomi'c M，Gverovi'c Antunica A，et al.Body mass index：a risk factor for retinopathy in type 2 diabetic patients[J].Mediators Inf1amm，2013，2013：436329.
[7]	Zhao C，Wang W，Xu D，et al.Insu1in and risk of diabetic retinopathy in patients with type 2 diabetes me11itus：data from a meta-ana1ysis of seven cohort studies[J].Diagn Patho1，2014，9（1）：130.
[8]	Meguro S，Kabeya Y，Tanaka K，et al.Past obesity as we11 as present body weight status is a risk factor for diabetic nephropathy[J].Int J Endocrino1，2013，2013：590569.
[10]	Lu J，Hou X，Zhang L，et al.Association between body mass index and diabetic retinopathy in Chinese patients with type 2 diabetes[J].Acta Diabeto1，2015，52（4）：701-708.
[11]	田婷，马向华，沈捷.血清脂蛋白（a）和视黄醇结合蛋白4与2型糖尿病视网膜病变的相关性[J].南京医科大学学报·自然科学版，2011，31（11）：1620-1622.
[12]	Chen X，Zhao Y，Zhou Z，et al.Preva1ence and risk factors of diabetic retinopathy in Chongqing pre -diabetes patients[J].Eye (Lond)，2012，26（6）：816-820.
[13]	Zhong ZL，Han M，Chen S.Risk factors associated with retina1 neovascu1arization of diabetic retinopathy in type 2 diabetes me11itus[J].Int J Ophtha1mo1，2011，4（2）：182-185.
[14]	Kamstrup PR，Nordestgaard BG.Lipoprotein（a）concentrations，isoform size，andriskoftype2diabetes：aMende1ian randomization study[J].Lancet Diabetes Endocrino1，2013，1（3）：220-227.
[15]	Nordestgaard BG，Chapman MJ，Ray K，et al.Lipoprotein（a）as a cardiovascu1ar risk factor：current status[J].Eur Heart J，2010，31（23）：2844-2853.
[16]	Fujisawa M，Haramaki R，Miyazaki H，et al.Ro1e of 1ipoprotein（a）and TGF-beta 1 in atherosc1erosis of hemodia1ysis patients[J].J Am Soc Nephro1，2000，11（10）：1889-1895.
[17]	Chopra R，Saramma JG，Mary J，et al.Lipoprotein（a）as a risk factor for diabetic retinopathy in patients with type 2 diabetes me11itus[J].Indian J Ophtha1mo1，2007，55（3）：195-198.
[18]	Onat A，Yazici M，Hergenç G，et al.Lipoprotein（a）in a popu1ation-based study：more significant in Turkish women than men?[J].Anado1u Kardiyo1 Derg，2005，5（4）：271-277.